These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7899229)

  • 1. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs.
    Elmquist WF; Chan KK; Sawchuk RJ
    Pharm Res; 1994 Dec; 11(12):1689-97. PubMed ID: 7899229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial.
    Efe T; Sagnak E; Roessler PP; Getgood A; Patzer T; Fuchs-Winkelmann S; Peterlein CD; Schofer MD
    Knee Surg Sports Traumatol Arthrosc; 2014 Feb; 22(2):345-50. PubMed ID: 23338668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Sep; 33(3):184-213. PubMed ID: 9314611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of combined therapy on the ortofen concentration of the blood plasma and synovial fluid in patients with rheumatoid arthritis].
    Stanislavchuk MA
    Lik Sprava; 1999 Jul; (5):79-82. PubMed ID: 10822685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.
    Sacerdote P; Carrabba M; Galante A; Pisati R; Manfredi B; Panerai AE
    Inflamm Res; 1995 Nov; 44(11):486-90. PubMed ID: 8597883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue concentration of the active substance of Voltaren SR 75 in articular cartilage, synovial membrane and bone.
    Bender T; Schäfer M; Bariska J
    Clin Rheumatol; 2000; 19(2):89-91. PubMed ID: 10791617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
    Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine and nonsteroidal antiinflammatory drugs: exploring potential drug interactions and their implications for the treatment of rheumatoid arthritis.
    Kovarik JM; Mueller EA; Gerbeau C; Tarral A; Francheteau P; Guerret M
    J Clin Pharmacol; 1997 Apr; 37(4):336-43. PubMed ID: 9115060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications.
    Miyatake S; Ichiyama H; Kondo E; Yasuda K
    Br J Clin Pharmacol; 2009 Jan; 67(1):125-9. PubMed ID: 19133062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prostaglandin E synthesis by steroidal and nonsteroidal antiinflammatory drugs in human synovial fibroblast cultures.
    Yaron M; Yaron I; Mashiah V
    J Rheumatol; 1984 Aug; 11(4):488-92. PubMed ID: 6481721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen.
    Giagoudakis G; Markantonis SL
    Pharmacotherapy; 2005 Jan; 25(1):18-25. PubMed ID: 15767216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transsynovial distribution of oxaprozin.
    Kurowski M; Thabe H
    Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.